iBio, Inc. (IBIO)
1.125
+0.02
(+1.35%)
USD |
NASDAQ |
Oct 02, 16:00
1.09
-0.04
(-3.11%)
After-Hours: 20:00
iBio Price to Book Value : 0.7311 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.7311 |
| October 01, 2026 | 0.7213 |
| September 30, 2026 | 0.7668 |
| September 29, 2026 | 0.7603 |
| September 28, 2026 | 0.7603 |
| September 25, 2026 | 0.7733 |
| September 24, 2026 | 0.7798 |
| September 23, 2026 | 0.809 |
| September 22, 2026 | 0.8643 |
| September 21, 2026 | 0.8188 |
| September 18, 2026 | 0.8318 |
| September 17, 2026 | 0.8123 |
| September 16, 2026 | 0.7668 |
| September 15, 2026 | 0.7733 |
| September 14, 2026 | 0.7798 |
| September 11, 2026 | 0.783 |
| September 10, 2026 | 0.796 |
| September 09, 2026 | 0.8188 |
| September 08, 2026 | 0.8448 |
| September 04, 2026 | 0.8513 |
| September 03, 2026 | 0.8448 |
| September 02, 2026 | 0.8513 |
| September 01, 2026 | 0.8188 |
| August 31, 2026 | 0.8253 |
| August 28, 2026 | 0.8838 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.9098 |
| August 26, 2026 | 0.9293 |
| August 25, 2026 | 0.9552 |
| August 24, 2026 | 0.9228 |
| August 21, 2026 | 0.9293 |
| August 20, 2026 | 0.9552 |
| August 19, 2026 | 0.9682 |
| August 18, 2026 | 0.9423 |
| August 17, 2026 | 0.9423 |
| August 14, 2026 | 0.9293 |
| August 13, 2026 | 0.9098 |
| August 12, 2026 | 0.9552 |
| August 11, 2026 | 0.9552 |
| August 10, 2026 | 0.9098 |
| August 07, 2026 | 0.9163 |
| August 06, 2026 | 0.9033 |
| August 05, 2026 | 0.9098 |
| August 04, 2026 | 0.9487 |
| August 03, 2026 | 0.9228 |
| July 31, 2026 | 0.9098 |
| July 30, 2026 | 0.9033 |
| July 29, 2026 | 0.8838 |
| July 28, 2026 | 0.9033 |
| July 27, 2026 | 0.9423 |
| July 24, 2026 | 0.9293 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Savara, Inc. | 6.877 |
| Vericel Corp. | 5.552 |
| Biogen, Inc. | 1.723 |
Price to Book Value Related Metrics
| PS Ratio | 920.85 |
| Price | 1.125 |
| Earnings Yield | -40.32% |
| Market Cap | 62.66M |